Obesity Trial, Recruiting NCT06207110 Sponsor: University of California, San Diego Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06207110
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child and their parent or guardian must agree to take part, with the child giving their assent and the parent giving formal consent
  • The child must be between 7 and 12 years old and have a body weight classified as overweight or obese (at or above the 85th percentile for BMI)
  • The child must score highly on a measure of food responsiveness — specifically, a score of 3.8 or higher on a standard questionnaire about how strongly a child is drawn to food
  • A parent or caregiver who is responsible for preparing the family's food must be willing to take part and must be able to read, speak, and understand English at roughly a primary school level
  • The whole family must be willing to attend all appointments and sessions, agree to be randomly assigned to a treatment group, and take part in all parts of the study
  • If the child takes any medication that can affect body weight, they must have been on a stable dose of that medication for at least 3 months
  • The child must be able to take part in physical activity throughout the study, and the parent must be able to either join the child in physical activity or arrange opportunities for the child to do the recommended activities

Who may not be able to join:

  • Children who have an active, serious mental health condition, such as current suicidal thoughts, a recent psychiatric hospitalisation, psychosis, or bulimia nervosa
  • Children who have a serious long-term physical health condition (for example, cystic fibrosis or type 1 diabetes) where a doctor would normally need to directly oversee any changes to diet or exercise
  • Children who are currently taking medication specifically for weight loss
  • Parents or caregivers who have an active, serious mental health condition, such as current suicidal thoughts, a recent psychiatric hospitalisation, psychosis, bipolar disorder, borderline personality disorder, or a moderate to severe alcohol or substance use disorder
  • Families where a close relative or someone living in the household has a diagnosis of anorexia nervosa or bulimia nervosa
  • Children or parents whose medical or psychological situation could make it unsafe or very difficult to follow the study plan (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kerri Boutelle, Ph.D., UC San Diego

Phone: 1-855-827-3498

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 April 2024
Est. completion
1 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Child age and sex adjusted body mass index z-score (BMIz); Child percentage of the 95th percentile BMI (%BMIp95); Change in Child Overeating

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov